Study Links Prenatal Paracetamol Exposure to Differences in Female Reproductive Development

Researchers in Denmark have identified differences in ovarian development among girls exposed to paracetamol (Tylenol) in the womb. These findings suggest a potential link between prenatal exposure and markers of reproductive health.

Dr. Margit Bistrup Fischer, from the Department of Growth and Reproduction at Rigshospitalet in Copenhagen, emphasizes the importance of cautious interpretation. The study, published in Human Reproduction Open, followed 302 girls through infancy. Researchers collected data on paracetamol usage during pregnancy using questionnaires and urine samples.

Key Findings

• Girls exposed to paracetamol in utero showed smaller ovaries and uterine volumes.
• Early exposure resulted in reduced ovarian volume and smaller uterine volume.
• Later exposure was linked to fewer ovarian follicles.
• Lower levels of anti-Müllerian hormone (AMH) were seen among some exposed girls.

The study involved an additional cohort of 1,210 girls, confirming similar trends. Prenatal exposure correlated with smaller uterine volume at puberty and reduced ovarian volume during adolescence.

Considerations and Health Advice

Paracetamol use during pregnancy is common, with more than half of pregnant women reportedly taking it. Animal studies have suggested potential effects on reproductive lifespan, prompting this human-focused research.

While findings highlight differences in markers, the impact on fertility remains uncertain. “For this we need larger studies with longer follow-up,” Dr. Fischer notes, stressing that current medical guidelines should still be followed. Dr. Lucy Hooper, not involved in the study, advises caution in interpreting results due to the small sample size of early exposures.

Pregnant women should discuss symptoms with healthcare professionals, considering alternatives when feasible. Dr. Fischer highlights the individual approach in medication use, consulting healthcare advice.

Regulatory Perspectives

Fischer indicates that discussions about changing medical recommendations require further evaluation by authorities. The study encourages a thorough assessment of paracetamol use during pregnancy, especially in situations without severe pain or fever.

For more details, refer to the study authors and consult Newsweek: Kara Dolman and Emma Lee-Sang for editorial queries.